Schizophrenia 25 Sep, 2019 Video #6: Which patients are best suited for long-acting injectable antipsychotics? Professor John Kane discusses the often-asked question, who is the ideal candidate for long-acting antipsychotic treatment? Sign up for Progress in Mind Middle East and Africa Sign up for our newsletter and stay updated on new content and resources. Related Mental Health Article Disclosure can create a virtuous circle as solidarity replaces stigma Migraine Parkinson's Disease Congress highlights Article Highlights from EAN 2022 — Day 1 — June 25th Depression Article New understanding of the gut microbiome may be the key to many diseases and pave the way for new therapies